沙特阿拉伯利雅得癌症患者对禁忌症的认识:一项横断面研究。

IF 2.5 4区 医学 Q3 ONCOLOGY Cancer Control Pub Date : 2025-01-01 DOI:10.1177/10732748251313498
Mansour Almuqbil, Rama Abdulhamid Mohammed Alobaid, Amouna Abdulrahim Mazal Alhamad, Noor Hussam Eddin, Nora Al Yahya, Walaa F Alsanie, Abdulhakeem S Alamri, Majid Alhomrani, Amal F Alshammary, Rafiulla Gilkaramenthi, Syed Mohammed Basheeruddin Asdaq
{"title":"沙特阿拉伯利雅得癌症患者对禁忌症的认识:一项横断面研究。","authors":"Mansour Almuqbil, Rama Abdulhamid Mohammed Alobaid, Amouna Abdulrahim Mazal Alhamad, Noor Hussam Eddin, Nora Al Yahya, Walaa F Alsanie, Abdulhakeem S Alamri, Majid Alhomrani, Amal F Alshammary, Rafiulla Gilkaramenthi, Syed Mohammed Basheeruddin Asdaq","doi":"10.1177/10732748251313498","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Cancer patients often face challenges in managing their disease, particularly with regard to contraindications related to medications, foods, and physical activity, which can negatively affect treatment outcomes. This study aimed to evaluate cancer patients' awareness of these contraindications and to explore the influence of sociodemographic factors, support systems, comorbidities, and medication use on their knowledge.</p><p><strong>Methods: </strong>A cross-sectional prospective study was conducted with 125 cancer patients in Saudi Arabia between December 2022 and February 2023. Participants were selected using purposive sampling, and data were collected through a validated questionnaire. Multinomial regression analysis was employed to identify the predictors of awareness of contraindicated medications, foods, and other environmental factors.</p><p><strong>Results: </strong>Nationality, co-morbidities, and cancer duration were significant predictors of awareness regarding contraindicated drugs. Saudi patients were more likely to be aware of contraindicated medications (<i>P</i> = 0.010), and those without chronic diseases were 15 times more likely to know about drug contraindications (OR = 15.076, 95% CI: 3.442-66.042). Cancer diagnosis (<i>P</i> = 0.033) and cancer duration (<i>P</i> = 0.022) were also significant for food contraindications. Over 58% were unaware of the need to regulate body temperature during treatment. Location influenced exercise awareness (<i>P</i> = 0.064) and complementary and alternative medicine (CAM) awareness, with rural participants showing higher CAM knowledge (<i>P</i> = 0.001).</p><p><strong>Conclusion: </strong>This study emphasizes the need to improve cancer patients' awareness of contraindications, particularly regarding medications and foods. Key factors influencing awareness include nationality, co-morbidities, and cancer duration. While family support is beneficial, it doesn't directly enhance knowledge, highlighting the importance of targeted educational interventions to improve patient outcomes and safety.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":"32 ","pages":"10732748251313498"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742164/pdf/","citationCount":"0","resultStr":"{\"title\":\"Awareness of Contraindications Among Cancer Patients in Riyadh, Saudi Arabia: A Cross-Sectional Study.\",\"authors\":\"Mansour Almuqbil, Rama Abdulhamid Mohammed Alobaid, Amouna Abdulrahim Mazal Alhamad, Noor Hussam Eddin, Nora Al Yahya, Walaa F Alsanie, Abdulhakeem S Alamri, Majid Alhomrani, Amal F Alshammary, Rafiulla Gilkaramenthi, Syed Mohammed Basheeruddin Asdaq\",\"doi\":\"10.1177/10732748251313498\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Cancer patients often face challenges in managing their disease, particularly with regard to contraindications related to medications, foods, and physical activity, which can negatively affect treatment outcomes. This study aimed to evaluate cancer patients' awareness of these contraindications and to explore the influence of sociodemographic factors, support systems, comorbidities, and medication use on their knowledge.</p><p><strong>Methods: </strong>A cross-sectional prospective study was conducted with 125 cancer patients in Saudi Arabia between December 2022 and February 2023. Participants were selected using purposive sampling, and data were collected through a validated questionnaire. Multinomial regression analysis was employed to identify the predictors of awareness of contraindicated medications, foods, and other environmental factors.</p><p><strong>Results: </strong>Nationality, co-morbidities, and cancer duration were significant predictors of awareness regarding contraindicated drugs. Saudi patients were more likely to be aware of contraindicated medications (<i>P</i> = 0.010), and those without chronic diseases were 15 times more likely to know about drug contraindications (OR = 15.076, 95% CI: 3.442-66.042). Cancer diagnosis (<i>P</i> = 0.033) and cancer duration (<i>P</i> = 0.022) were also significant for food contraindications. Over 58% were unaware of the need to regulate body temperature during treatment. Location influenced exercise awareness (<i>P</i> = 0.064) and complementary and alternative medicine (CAM) awareness, with rural participants showing higher CAM knowledge (<i>P</i> = 0.001).</p><p><strong>Conclusion: </strong>This study emphasizes the need to improve cancer patients' awareness of contraindications, particularly regarding medications and foods. Key factors influencing awareness include nationality, co-morbidities, and cancer duration. While family support is beneficial, it doesn't directly enhance knowledge, highlighting the importance of targeted educational interventions to improve patient outcomes and safety.</p>\",\"PeriodicalId\":49093,\"journal\":{\"name\":\"Cancer Control\",\"volume\":\"32 \",\"pages\":\"10732748251313498\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742164/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Control\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/10732748251313498\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10732748251313498","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导读:癌症患者在控制疾病方面经常面临挑战,特别是与药物、食物和身体活动相关的禁忌症,这些禁忌症会对治疗结果产生负面影响。本研究旨在评估癌症患者对这些禁忌症的认知,并探讨社会人口因素、支持系统、合并症和药物使用对其认知的影响。方法:在2022年12月至2023年2月期间,对沙特阿拉伯的125例癌症患者进行了横断面前瞻性研究。参与者采用有目的的抽样选择,并通过有效的问卷调查收集数据。采用多项回归分析来确定对禁忌症药物、食物和其他环境因素的认识的预测因素。结果:国籍、合并症和癌症持续时间是对禁忌症药物认知的重要预测因素。沙特患者知晓禁忌症的可能性更高(P = 0.010),无慢性疾病患者知晓禁忌症的可能性高出15倍(OR = 15.076, 95% CI: 3.442 ~ 66.042)。癌症诊断(P = 0.033)和癌症持续时间(P = 0.022)与食物禁忌症也有显著关系。超过58%的人不知道在治疗过程中需要调节体温。地理位置影响运动意识(P = 0.064)和补充替代医学(CAM)意识,农村参与者的CAM知识更高(P = 0.001)。结论:本研究强调有必要提高癌症患者对禁忌症的认识,特别是对药物和食物的认识。影响认知的关键因素包括国籍、合并症和癌症病程。虽然家庭支持是有益的,但它并不能直接提高知识,这突出了有针对性的教育干预对改善患者预后和安全的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Awareness of Contraindications Among Cancer Patients in Riyadh, Saudi Arabia: A Cross-Sectional Study.

Introduction: Cancer patients often face challenges in managing their disease, particularly with regard to contraindications related to medications, foods, and physical activity, which can negatively affect treatment outcomes. This study aimed to evaluate cancer patients' awareness of these contraindications and to explore the influence of sociodemographic factors, support systems, comorbidities, and medication use on their knowledge.

Methods: A cross-sectional prospective study was conducted with 125 cancer patients in Saudi Arabia between December 2022 and February 2023. Participants were selected using purposive sampling, and data were collected through a validated questionnaire. Multinomial regression analysis was employed to identify the predictors of awareness of contraindicated medications, foods, and other environmental factors.

Results: Nationality, co-morbidities, and cancer duration were significant predictors of awareness regarding contraindicated drugs. Saudi patients were more likely to be aware of contraindicated medications (P = 0.010), and those without chronic diseases were 15 times more likely to know about drug contraindications (OR = 15.076, 95% CI: 3.442-66.042). Cancer diagnosis (P = 0.033) and cancer duration (P = 0.022) were also significant for food contraindications. Over 58% were unaware of the need to regulate body temperature during treatment. Location influenced exercise awareness (P = 0.064) and complementary and alternative medicine (CAM) awareness, with rural participants showing higher CAM knowledge (P = 0.001).

Conclusion: This study emphasizes the need to improve cancer patients' awareness of contraindications, particularly regarding medications and foods. Key factors influencing awareness include nationality, co-morbidities, and cancer duration. While family support is beneficial, it doesn't directly enhance knowledge, highlighting the importance of targeted educational interventions to improve patient outcomes and safety.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer Control
Cancer Control ONCOLOGY-
CiteScore
3.80
自引率
0.00%
发文量
148
审稿时长
>12 weeks
期刊介绍: Cancer Control is a JCR-ranked, peer-reviewed open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Our vision is a world where gold-standard cancer care is the norm, not the exception.
期刊最新文献
Clinicopathological Features and Prognoses of Patients With Splenic Metastases From Breast Cancer: A Single-Centre, Retrospective Study. Epidemiological Features of Sinonasal Adenocarcinoma and Prognostic Nomogram: A Study Based on the SEER Database. Hepatitis B Virus Reactivation in Patients With HBV-Related Advanced Hepatocellular Carcinoma Undergoing Lenvatinib and Camrelizumab Treatment. Prognostic Value of Surgical Resection for Non-small-cell Lung Cancer Patients Comorbid With Minimal Pleural Effusion. Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with EGFR or KRAS Mutation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1